Genome Editing: US FDA Eyes Platform-Based Approach To Development And Approval

 
• By Sue Sutter
  
Diving platform
Genome editing poses special considerations for the platform approach to development and regulatory review. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies